Why TGTX Stock Is Rallying Today - InvestingChannel News

1 day ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

9%
OFF

Why TGTX Stock Is Rallying Today - InvestingChannel News

2 weeks from now

1 day ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

investingchannel.com

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

15 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

8%
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TGTX Price Action: TG Therapeutics shares were up 7.8% at $29.85 at the time of publication, according to Benzinga Pro. Photo: Shutterstock. Market News and Data brought to …

benzinga.com

30%
OFF

TG Therapeutics Stock Just Rallied 30%: What Happened? - MSN

2 weeks from now

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. The biotech stock is being …

msn.com

$89
OFF

TG Therapeutics, Inc. (TGTX) Latest Stock News - Seeking Alpha

2 weeks from now

Jan 6, 2025 · SA News Tue, Feb. 20, 2024 10 Comments TG Therapeutics prelim results see FY23 BRIUMVI U.S. revenue $89M; initiates FY24 outlook SA News Wed, Jan. 10, 2024 15 …

seekingalpha.com

82%
OFF

After Plunging -9.82% In 4 Weeks, Here's Why The Trend Might …

2 weeks from now

Apr 30, 2024 · TG Therapeutics (TGTX) has been on a downward spiral lately with significant selling pressure. After declining 9.8% over the past four weeks, the stock looks well positioned …

yahoo.com

26%
OFF

Should You Invest In TG Therapeutics (TGTX)?

2 weeks from now

5 days ago · The one-month return of TG Therapeutics, Inc. (NASDAQ:TGTX) was -6.26%, and its shares gained 67.07% of their value over the last 52 weeks. On January 8, 2025, TG …

investingchannel.com

36%
OFF

TG Therapeutics (TGTX) Stock Latest News - TGTX News Today

2 weeks from now

Nov 5, 2024 · TG Therapeutics Inc.'s stock TGTX, -1.36% rallied 11% early Wednesday, after the biotech said it's entered an agreement with microcap Precision BioSciencies Inc. DTIL, …

financecharts.com

10%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

The Price Action of TG Stock. In the last month the shares have fallen 10%, despite today's rally. However, they have advanced 23% in the previous three months.

msn.com

FAQs about Why TGTX Stock Is Rallying Today - InvestingChannel News Coupon?

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

What is tgtx's current price target?

TGTX's current price target is $40.67. Learn why top analysts are making this stock forecast for TG Therapeutics at MarketBeat. ...

Should you buy TG Therapeutics Inc (tgtx)?

TG Therapeutics Inc (TGTX) reports over 230% year-over-year revenue growth, raises full-year guidance, and outlines future growth strategies. AI stocks Meta Platforms and Oracle lead the parade of top five stocks to watch near buy points this week. Netflix, TG Therapeutics and GoDaddy also make the cut. ...

Why did TG Therapeutics stock crash Monday?

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts. TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 4.46%, respectively, for the quarter ended September 2024. ...

What does tgtx stand for?

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (TG) today announced the issuance of three additional patents by the United States Patent and Trademark Office (USPTO) ... ...

Will tgtx (tgtx) stock fall if it meets guidance?

Secondly, even TGTX meets guidance, the stock could fall due to weak future guidance. Current analyst estimates for 2025 revenues are $537.8M, and so guidance for a US sales number beyond that would be a nice positive. ...